 |
|
|
| |
8 weeks sofosbuvir/velpatasvir in genotype 3 patients with significant fibrosis:
Highly effective amongst an OST cohort
|
| |
| |
Reported by Jules Levin
EASL April 13 Paris France
Alison Boyle1, F Marra1, E Peters1 , M Heydtmann2 , H Cairns1,
S Datta3 , ST Barclay4
1Gartnavel General Hospital, Glasgow, Scotland, 2Royal Alexandra Hospital,
Paisley, Scotland, 3Queen Elizabeth University Hospital, Glasgow, Scotland,
4Glasgow Royal Infirmary, Glasgow, Scotland
|
| |
|
|
|
|
|
